The pharmaceutical company Esteve, a member of the CataloniaBio board of directors, will begin 2018 with a new Chairman of the Board, Albert Esteve, and a new Chief Executive Officer, Staffan Schüberg. These changes are part of the largest restructuring of its governing structure to date, a process the company initiated in 2016.

Albert Esteve, currently the CEO and Vice-president of the group, will replace Joan Esteve as Chairman of the Board. He commented, "This is a new challenge that I am facing with great enthusiasm. Consolidating the best practices in corporate governance initiated under the leadership of Joan Esteve, preserving the values that he has always defended and acted according to in his work on the Board, and fuelling the group’s growth. "

Additionally, Staffan Schüberg will head up executive management of the Esteve Group of companies, including all its business activities (chemicals, drug R&D and generics).

In 2018, Esteve will also be moving its corporate headquarters to Barcelona’s Zona Franca.

Photo: Left to right, Albert Esteve, Joan Esteve and Staffan Schüberg - © Esteve